Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Drug News & Perspectives|April 5, 2008
Angiogenesis: the new potential target for the therapy of psoriasis?Regina Heidenreich, Martin Röcken, Kamran Ghoreschi
International Journal of Experimental Pathology|July 1, 2009
Angiogenesis drives psoriasis pathogenesisRegina Heidenreich, Martin Röcken, Kamran Ghoreschi
Methods in Molecular Biology (Clifton, N.J.)|December 18, 2016
RNActive® Technology: Generation and Testing of Stable and Immunogenic mRNA VaccinesSusanne Rauch, Johannes Lutz, Aleksandra Kowalczyk, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 20, 2017
mRNA Cancer VaccinesKatja Fiedler, Sandra Lazzaro, Johannes Lutz, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2022
Local immunotherapy with the RNA-based immune stimulator CV8102 induces substantial anti-tumor responses and enhances checkpoint inhibitor activityJohannes Lutz, Michael Meister, Mohamed Habbeddine, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2024
Sequence-Optimized mRNA Vaccines Against Infectious DiseaseSusanne Rauch, Johannes Lutz, Janine Mühe, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2019
mRNA: A Novel Avenue to Antibody Therapy?Thomas Schlake, Moritz Thran, Katja Fiedler, et al.
Journal of Vascular Research|April 18, 2008
Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter miceRegina Heidenreich, Toshinori Murayama, Marcy Silver, et al.
Blood|February 4, 2009
EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasionAlexandra Ziegler, Regina Heidenreich, Heidi Braumüller, et al.
Vaccine|June 9, 2016
Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunityAleksandra Kowalczyk, Fatma Doener, Kai Zanzinger, et al.
Pageof 3